Protective effects of 17β-estradiol and trivalent chromium on interleukin-6 secretion, oxidative stress, and adhesion of monocytes: Relevance to heart disease in postmenopausal women

Free Radical Biology and Medicine

Volumn 37, Issue 11, 2004, Pages 1730-1735

  Jain, Sumati K ^a   Rogier, Kimberly ^b   Prouty, Leonard ^b   Jain, Sushil K ^b  

^a Caddo Magnet High School   (United States)

^b Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

Diabetes; Free radicals; Heart disease; Interleukin 6; Menopause; Oxidative stress

Indexed keywords

CHROMIUM; ESTRADIOL; INTERLEUKIN 6; ANTIOXIDANT; CHLORIDE; CHROMIUM CHLORIDE; CHROMIUM DERIVATIVE; GLUCOSE;

ARTICLE; CELL ADHESION; CELL CULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; HEART DISEASE; HUMAN; HUMAN CELL; LIPID PEROXIDATION; MENOPAUSAL SYNDROME; MONOCYTE; OXIDATIVE STRESS; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; STATISTICAL SIGNIFICANCE; BIOSYNTHESIS; CELL STRAIN U937; DIABETES MELLITUS; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; IMMUNOLOGY;

ANTIOXIDANTS; CELL ADHESION; CELLS, CULTURED; CHLORIDES; CHROMIUM COMPOUNDS; DIABETES COMPLICATIONS; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; GLUCOSE; HEART DISEASES; HUMANS; INTERLEUKIN-6; MONOCYTES; OXIDATIVE STRESS; POSTMENOPAUSE; U937 CELLS;

EID: 7444220588     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2004.08.003     Document Type: Article

References (33)

1. Women, Heart Disease and Stroke: http://www.americanheart.org/heart_and stroke_A_Z_Guide/women.html
2. L. Mosca, J.E. Manson, S.E. Sutherland, R.D. Langer, T. Manolio, and E. Barett-Connor Cardiovascular disease in women, a statement for health care professionals from American Diabetes Association writing Group Circulation 96 1997 2468 2482
3. J.R. Sowers Diabetes mellitus and cardiovascular disease in women Arch. Internal. Med. 158 1998 617 621
4. C.J. Crespo, E. Smit, A. Snelling, C.T. Sempos, and R.E. Andersen Hormone replacement therapy and its relationship to lipid and glucose metabolism in diabetic and nondiabetic postmenopausal women Diab. Care 2002 1675 1680
5. V. Jayagopal, P.A. Albertazzi, E.S. Kilpatrick, E.M. Howrath, P.E. Jennings, D.A. Hepburn, and S.L. Atkin Beneficial effects of soy phytoestrogen intake in postmenopausal women with type-2 diabetes Diab. Care 25 2002 1709 1714
6. J.A. Cauley, D.G. Seeley, W.S. Browner, K. Ensrud, L.H. Kuller, R.C. Lipschutz, and S.B. Hulley Estrogen replacement therapy and mortality among older women: the study of osteoporotic fractures Arch. Intern. Med. 157 1997 2181 2187
7. Writing Group for the Women's Health Initiative Investigators Risk and benefits of estrogen plus progestin in healthy post-menopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 2002 321 333
8. J. Buse, and L. Raftery What we think and what we know Diab. Care 25 2002 1876 1877
9. H. Burger Hormone replacement therapy in the post-women's health initiative era Climacteric (Suppl.) 1 2003 11 36
10. F. Labrie, M. El-Alfy, L. Berger, C. Labrie, C. Martel, A. Belanger, B. Candas, and G. Pelletier The combination of a novel selective estrogen receptor modulator with an estrogen protects the mammary gland and uterus in a rodent model: the future of post-menopausal women's health? Endocrinology 144 2003 4700 4706
11. G.J. Blake, and P.M. Ridker Inflammatory biomarkers and cardiovascular risk prediction J. Intern. Med. 252 2002 283 294
12. J.S. Yudkin, M. Kumari, S.E. Humphries, and V. Mohamed-Ali Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link Atherosclerosis 148 2000 209 214
13. J.P. Bastard, M. Maachi, J.T. Van Nhieu, C. Jardel, E. Bruckert, A. Grimaldi, J.J. Robert, J. Capeau, and B. Hainque Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro J. Clin. Endocrinol. Metab. 87 2002 2084 2089
14. B. Vozarova, C. Weyer, K. Hanson, P.A. Tataranni, C. Bogardus, and R.E. Pratley Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion Obes. Res. 9 2001 414 417
15. C. Scheidt-Nave, H. Bismar, G. Leidig-Bruckner, H. Woitge, M.J. Seibel, R. Zeigler, and J. Pfeilschifter Serum intrleukin-6 is a major predictor of bone loss in women specific to the first decade past menopause J. Clin. Endocrinol. Metab. 86 2001 2032 2042
16. Y. Huo, and K. Ley Adhesion molecules and atherogenesis Acta. Physiol. Scand. 173 2001 35 43
17. P.A. Castelnau, R.S. Garrett, and W. Palinski Abnormal iron deposition associated with lipid peroxidation in transgenic mice expressing interleukin-6 in the brain J. Neuropathol. Ex. Neurol. 57 1998 268 282
18. S. Cuzzocrea, G. De Sarro, and G. Costantino IL-6 knock out mice exhibit resistance to splanchnic artery occlusion shock J. Leukoc. Biol. 66 1999 471 480
19. D.J. Rader Inflammatory markers of coronary risk New Engl. J. Med. 343 2000 1179 1182
20. S. Amar, K. Oyaisu, L. Li, and T. Van Dyke Moesin: a potential LPS receptor on monocytes J. Endotoxin Res. 7 2001 281 286
21. 2-treated U937 monocytes Free Radic. Biol. Med. 36 2004 423 428
22. H. Esterbauer, J. Lang, S. Zadravec, and S. Slater Detection of malondialdehyde by high performance liquid chromatography Methods Enzymol. 105 1984 319 328
23. W. Erl, C. Weber, C. Wardemann, and P. Weber Adhesion properties of Mno Mac 6, a monocytic cell line with characteristics of mature monocytes Atherosclerosis 113 1995 99 107
24. S.K. Jain, and K. Kannan Chromium chloride inhibits oxidative stress and TNF-α secretion caused by exposure to high glucose in cultured U937 monocytes Biochem. Biophys. Res. Commun. 289 2001 687 691
25. R.A. Anderson Potential antioxidant effect of zinc and chromium supplementation in people with type 2 diabetes mellitus J. Amer. Coll. Nutr. 20 2001 212 218
26. J.A. Vinson, M.A. Mandarano, D.L. Shuta, M. Bagchi, and D. Bagchi Beneficial effects of a novel IH636 grape seed propanthocyanidine extract and a niacin-bound chromium in a hamster atherosclerotic model Mol. Cell. Biochem. 240 2002 99 103
27. J.A. Vinson, and P. Bose The effect of a high chromium yeast on the blood glucose control and blood lipids of normal and diabetic human subjects Nutr. Rep. Int. 30 1984 911 918
28. J.A. Vinson, and K. Hsiao Comparitive effect of various forms of chromium on serum glucose: an assay for biologically active chromium Nutr. Rep. Int. 32 1985 1 7
29. M. Morohoshi, K. Fujisawa, I. Uchimura, and F. Numano The effect of glucose and advance glycosylation end products on IL-6 production by human monocytes Ann. NY Acad. Sci. 748 1995 562 570
30. I. Jialal, S. Devraj, and S.K. Venogopal Oxidative stress, inflammation, and diabetic vasculopathies: The role of alpha tocopherol therapy Free. Radic. Res. 36 2002 1331 1336
31. S.K. Jain Hyperglycemia can cause membrane lipid peroxidation and osmotic fragility in human red blood cells J. Biol. Chem. 264 1989 21340 21345
32. I. Jialal, S. Devaraj, and N. Kaul The effect of alpha-tocopherol on monocyte proatherogenic activity J. Nutr. 131 2001 389S 394S
33. Chromium and Diabetes Workshop. Published by the Office of Dietary Supplements, National Institutes of Health, Bethesda, MD; 1999. http://ods.nih.gov/news/conferences/chromium_diabetes.html.